Cencora, Inc. (LON:0HF3)
London · Delayed Price · Currency is GBP · Price in USD 371.59
+10.38 (2.87%)
Feb 12, 2026, 4:54 PM GMT
Cencora Employees
Cencora had 51,000 employees as of September 30, 2025. The number of employees increased by 5,000 or 10.87% compared to the previous year.
Employees
51,000
Change (1Y)
5,000
Growth (1Y)
10.87%
Revenue / Employee
4.94M GBP
Profits / Employee
24.64K GBP
Market Cap
52.14B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2025 | 51,000 | 5,000 | 10.87% | 47,000 | 4,000 |
| Sep 30, 2024 | 46,000 | 0 | - | 42,000 | 4,000 |
| Sep 30, 2023 | 46,000 | 2,000 | 4.55% | 42,000 | 4,000 |
| Sep 30, 2022 | 44,000 | 2,000 | 4.76% | 39,000 | 5,000 |
| Sep 30, 2021 | 42,000 | 20,000 | 90.91% | 38,000 | 4,000 |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,000 |
| Convatec Group | 10,000 |
| Hikma Pharmaceuticals | 9,500 |
| CVS Group | 8,850 |
| Genus | 3,190 |
Cencora News
- 2 days ago - Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056 - Business Wire
- 8 days ago - Cencora, Inc. (COR) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Cencora beats quarterly profit estimates on strong demand for specialty medicines - Reuters
- 8 days ago - Cencora Reports Fiscal 2026 First Quarter Results - Business Wire
- 21 days ago - Curant Rare Announces Collaboration with Cencora to Support Commercialization of Rare and Orphan Drug Products - Business Wire
- 21 days ago - Cencora Elects Ellen Cooper to Its Board of Directors - Business Wire
- 22 days ago - Cencora: High-Growth Specialty Services Firm Disguised As A Distributor - Seeking Alpha
- 4 weeks ago - Cencora, Inc. (COR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha